Last reviewed · How we verify

NCT03632824

Tranexamic Acid in Pregnancies With Vaginal Bleeding

Completed NA Last updated 22 January 2020
What this trial tests

NA trial testing Tranexamic Acid in Vaginal Bleeding During Pregnancy in 139 participants. Completed in 18 January 2020.

Timeline
1 February 2016
Primary endpoint
15 January 2020
18 January 2020

Quick facts

Lead sponsorHawler Medical University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingnone
Primary purposetreatment
Enrollment139
Start date1 February 2016
Primary completion15 January 2020
Estimated completion18 January 2020
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

Hawler Medical University

Who can join

Adults 18 to 42, female only, with Vaginal Bleeding During Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tranexamic acid has been proposed and used for prevention and management of antepartum and postpartum hemorrhage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Tranexamic Acid

Trials testing the same drug.

Other Hawler Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03632824.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing